Financial toxicity is the term researchers use for the material, psychological, and social burden associated with the cost of cancer care. It encompasses direct out-of-pocket expenses, lost income, disrupted employment, and the downstream effects of financial strain on patients and their households. Over the past decade, a growing body of evidence has linked financial hardship to worse quality of life, heavier symptom burden, treatment nonadherence, and adverse psychosocial outcomes across cancer types. Patients with hematologic malignancies such as multiple myeloma are considered especially vulnerable, because their treatment trajectories are long, their care pathways are complex, and modern therapy leans heavily on high-cost drugs delivered over many years.

Autologous stem cell transplant, or ASCT, remains a cornerstone of treatment for eligible myeloma patients and is associated with improved survival and disease control. But the procedure demands intensive preparation: prolonged engagement with the health care system, frequent travel, extended time away from work, and substantial reliance on unpaid informal caregivers. Even among insured patients, studies have documented depleted savings, lost income, and long-term financial insecurity. Quantitative work suggests nearly half of transplant patients experience meaningful financial hardship, and that this burden tracks with worse health-related quality of life and mental health. Yet most of this evidence comes from cross-sectional surveys and standardized instruments such as the Comprehensive Score for Financial Toxicity, which establish prevalence but reveal little about how strain is lived and negotiated in real time.

To close that gap, Halpin turned to data from the Ready for Transplant evaluation, an ethnographic quality improvement initiative run over roughly 18 months at a large U.S. academic cancer center. The project was originally designed to improve patient education for people preparing for ASCT, not to study money. But as Halpin reviewed the material, consistent patterns of embedded financial strain kept surfacing, prompting a focused secondary analysis. The dataset included approximately 150 hours of ethnographic observation across 70 nurse-patient education encounters, along with 35 semistructured interviews with patients, many conducted in their hospital rooms during the first days of admission for transplant. Education sessions themselves were lengthy, averaging 89 minutes and ranging from 36 to 124 minutes, giving researchers a detailed window into how transplant preparation was communicated and absorbed.

The patient population reflected the typical transplant cohort: average age 64, with participants ranging from 29 to 77 years old, evenly split by sex, predominantly White, and mostly married. Most arrived accompanied by spouses or adult children who took active roles in the sessions. Using conventional qualitative content analysis, with financial toxicity serving as a sensitizing concept rather than a rigid coding framework, Halpin deliberately distinguished experiences with clear resource implications, such as missed work or lodging costs, from broader expressions of emotional overwhelm. This boundary-setting was designed to avoid over-interpreting ordinary treatment burden as financial distress, a risk in any secondary analysis.

The most striking finding was what did not appear. Explicit discussion of out-of-pocket costs, insurance coverage, or affordability was uncommon across interviews, observations, and field notes. Financial toxicity instead surfaced indirectly, enacted through patterns of accommodation and endurance rather than articulated as complaint. When one patient reacted to the launch of transplant preparation by saying, “They are throwing everything at me at once,” the comment was framed as cognitive overload but occurred amid same-day scheduling of multiple appointments, new medications, and ongoing travel, conditions that entail time away from work, transportation costs, and logistical strain for everyone involved. When a nurse apologized for the sheer number of required appointments, a caregiver quipped, “If it’s a scavenger hunt then we need to get something fun in the end,” using humor to normalize the added time and travel.

Even when financial trade-offs became explicit, participants often deferred them in favor of perceived medical necessity. In one session, a nurse explained that a medication could reduce the risk of severe mouth sores but would require additional days spent lodging near the transplant center. Rather than questioning the cost of the extended stay, the caregiver responded, “I prefer to be on the safe side,” while the conversation turned to possible grant funding and cheaper nearby hotels. Halpin interprets such exchanges as moral commitments to safety effectively backgrounding cost while still absorbing its consequences, a pattern consistent with earlier qualitative work showing that patients avoid raising financial concerns for fear of appearing noncompliant or ungrateful in the context of serious illness.

Work and income disruption emerged as a central, if unspoken, dimension of strain. One employed patient tried to align procedure dates with work obligations across his family network; when his son could not drive him on a treatment day because of his own job, the discussion turned to rescheduling. “Transportation was ‘not the problem,'” the patient explained, “but rather ‘getting everybody lined up on the same day,'” a phrasing that implicitly acknowledged the limits imposed by employment. Caregivers’ constraints were even more visible: one asked when to plan “three weeks of vacation” to support his spouse, while another said he would “just move some things around at work,” minimizing what likely represented significant occupational trade-offs. Travel compounded everything. One patient lived nearly four hours from the center and depended on multiple relatives for rides, while another couple, shut out of subsidized housing, paid more than $200 per night at a nearby hotel as the caregiver actively hunted for alternatives. A patient who forgot to fast for a scan had to return the next day, adding yet another trip. These are the “hidden costs” of cancer care, transportation and lodging that insurance rarely covers and that clinicians often treat as unavoidable rather than as targets for intervention.

Caregiver labor formed the third pillar of the findings, and perhaps the most underrecognized. Family members coordinated appointments, managed medications, administered subcutaneous injections, maintained external catheters, and served as de facto financial navigators, all without pay or formal recognition. One caregiver declared, “I’ll do this. I have watched the videos,” when discussing infection-preventing dressing changes. Field notes recorded caregivers growing visibly uncomfortable during marathon sessions, repeatedly leaving the room or appearing agitated. Patients, meanwhile, oriented to the moral weight of this dependence: one noted his husband “is the one who remembers things about my treatment,” others fretted over missing birthdays and holidays, and one reminded himself that “other people are worse off than me.” In the United States, where paid leave for caregivers remains limited and uneven, such demands can force unpaid leave, reduced hours, or workforce exit, amplifying strain at the household level while remaining invisible in clinical decision-making.

The implications are significant. Screening tools that rely on direct questions about affordability may miss meaningful burden, particularly during the preparatory phase of transplant, when strain is distributed across time, geography, and family networks in ways that resist naming. Halpin argues that financial toxicity may be more readily identified by attending to logistical strain, caregiver labor, and repeated negotiations over travel and work, and that proactive financial navigation should begin during treatment planning, before transplant initiation, rather than after costs have accumulated. The study carries limitations typical of its design: it draws on data from a single academic center, was collected for a different original purpose, and was coded by a single researcher, though rigorous memoing, an audit trail, and attention to contrast cases were used to guard against interpretive drift. Even so, the ethnographic depth captures processes that surveys cannot. For a treatment as intensive as ASCT, the message is clear: the true cost of a stem cell transplant is paid not only in dollars, but in days, miles, and the quiet labor of the people who show up to help.

Subject of Research: Financial toxicity during autologous stem cell transplant preparation for multiple myeloma

Article Title: Financial toxicity as logistical and relational burden across the lifespan during autologous transplant preparation

Article References: Halpin, S. N. (2026). Financial toxicity as logistical and relational burden across the lifespan during autologous transplant preparation. Frontiers in Cancer Control and Society, 4, Article 1818523. https://doi.org/10.3389/fcacs.2026.1818523

Image Credits: AI Generated

DOI: 10.3389/fcacs.2026.1818523

Keywords: financial toxicity, multiple myeloma, autologous stem cell transplant, caregiver burden, qualitative research, cancer care costs, time toxicity, patient education, health disparities, cancer survivorship, work disruption, financial navigation